CTS CORP (CTS) FY2025 10-K Annual Report
CTS CORP (CTS) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Feb 24, 2026. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.
CTS CORP FY2025 10-K Analysis
Business Overview
- • Core business model information not detailed; filing focuses on equity compensation and governance
- • Equity compensation plans include 786,209 securities outstanding with $36.48 weighted-average exercise price
- • 1,017,684 shares available for future issuance under approved equity plans as of December 31, 2025
- • Deferred stock accounts hold 4,722 CTS common stock units for non-employee directors, plan amended in 2004
- • No new products, segments, or strategic shifts disclosed in business section this year
Management Discussion & Analysis
- • Revenue $541.3M, up 5.2% YoY ($26.6M increase) driven by aerospace, defense, medical markets, SyQwest acquisition adding $22.3M
- • Gross margin 38.4% vs 36.4%, operating margin 15.3% vs 13.8%, net earnings $65.3M up 17.7%, diluted EPS $2.19 vs $1.81
- • Best segment: diversified end markets up $43.0M or 16.3%; worst segment: transportation down $16.4M or 6.6%
- • Operating cash flow $102.1M; capital expenditures $15.7M; treasury stock repurchases $56.2M; dividends $4.8M; debt reduced by $34.8M
- • New $300M revolving credit facility secured, matures 2030, management expects adequate liquidity; risk includes market softness and EPA settlement charge
Risk Factors
- • Acquisition of SyQwest for $121.9M on July 29, 2024, funded by cash and borrowings under prior revolving credit facility
- • Exposure to cyclicality in transportation market; warranty reserves 0.3%-0.4% of net sales, impacting product quality liability estimates
- • Operating lease obligations $25.3M with $3.45M due within 12 months for land, buildings, equipment critical to operations
- • Goodwill impairment testing relies on market capitalization and discount rates; risk of impairment if market cap declines significantly
- • Long-term debt $57.5M principal under Revolving Credit Facility with $12.0M interest payments through maturity, interest rate swaps hedge $50M through Dec 2026
CTS CORP FY2025 Key Financial MetricsXBRL
Revenue
$541M
▲ +5.0% YoY
Net Income
$65M
▲ +12.4% YoY
Gross Margin
38.4%
▲ +176bp YoY
Operating Margin
15.3%
▲ +116bp YoY
Net Margin
12.1%
▲ +80bp YoY
ROE
11.8%
▲ +89bp YoY
Total Assets
$764M
▼ -0.2% YoY
EPS (Diluted)
$2.19
▲ +15.9% YoY
Operating Cash Flow
$102M
▲ +2.8% YoY
Source: XBRL data from CTS CORP FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on CTS CORP
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.